1992
DOI: 10.1016/0016-5085(92)91454-c
|View full text |Cite
|
Sign up to set email alerts
|

Role of nitric oxide in gastrointestinal and hepatic function and disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
203
2
10

Year Published

1995
1995
2017
2017

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 467 publications
(221 citation statements)
references
References 218 publications
5
203
2
10
Order By: Relevance
“…An attractive possibility is that LPS induces alterations in the paracrine control of gastric emptying via locally released cytokines. For instance, endotoxin-induced intestinal vascular damage is known to be mediated by cytokines such as nitric oxide, platelet-activating factor and thromboxane A2 (14). Alternatively, the LPS-induced gastric disturbance may be the result of an action of this bacterial endotoxin on specific areas of the CNS which control some of the gastric functions via the vagus nerve.…”
Section: Introductionmentioning
confidence: 99%
“…An attractive possibility is that LPS induces alterations in the paracrine control of gastric emptying via locally released cytokines. For instance, endotoxin-induced intestinal vascular damage is known to be mediated by cytokines such as nitric oxide, platelet-activating factor and thromboxane A2 (14). Alternatively, the LPS-induced gastric disturbance may be the result of an action of this bacterial endotoxin on specific areas of the CNS which control some of the gastric functions via the vagus nerve.…”
Section: Introductionmentioning
confidence: 99%
“…Nitric oxide (NO) is the principal inhibitory neurotransmitter in the gut, endothelial-derived NO is involved in the local regulation of mucosal blood flow and inflammatory-derived NO is involved in the loss of mucosal integrity [27,1]. Increased production of NO and subsequent local cytotoxicity to mucosal epithelial cells has been proposed as one of the putative mechanisms in the development of necrotizing enterocolitis (NEC) [6].…”
Section: Discussionmentioning
confidence: 99%
“…It should be noted that with systemic administration there is a possibility that some of the N OS inhibitor will be trapped in the liver (Stark and Szurszewski, 1992) as well as other systemic tissues, making it important to measure the degree of NOS inhibition directly. Systemic administration of L-NAME, however, induces marked increases in blood pres sure (Rees et aI., 1990), which can significantly alter the course of an ischemic insult and influence the degree of infarction.…”
Section: Discussionmentioning
confidence: 99%